Prevalence, severity, and clinical correlates of pain in patients with systemic sclerosis

Large descriptive studies of pain in systemic sclerosis (SSc) are lacking. The present study estimated prevalence, severity, and associations between SSc clinical variables and pain in all patients with SSc and in limited cutaneous (lcSSc) and diffuse cutaneous (dcSSc) subsets.

[1]  M. Fitzcharles,et al.  Patient barriers to pain management may contribute to poor pain control in rheumatoid arthritis. , 2009, The journal of pain : official journal of the American Pain Society.

[2]  M. Hudson,et al.  The cost of systemic sclerosis. , 2008, Arthritis and rheumatism.

[3]  L. Martire,et al.  Psychologic interventions and lifestyle modifications for arthritis pain management. , 2008, Rheumatic diseases clinics of North America.

[4]  M. Fitzcharles,et al.  New concepts in rheumatic pain. , 2008, Rheumatic diseases clinics of North America.

[5]  B. Thombs,et al.  Reliability and validity of the center for epidemiologic studies depression scale in patients with systemic sclerosis. , 2008, Arthritis and rheumatism.

[6]  R. Steele,et al.  Clinical correlates of quality of life in systemic sclerosis measured with the World Health Organization Disability Assessment Schedule II. , 2008, Arthritis and rheumatism.

[7]  R. Steele,et al.  Quality of life in systemic sclerosis: psychometric properties of the World Health Organization Disability Assessment Schedule II. , 2008, Arthritis and rheumatism.

[8]  Sander Greenland,et al.  Invited commentary: variable selection versus shrinkage in the control of multiple confounders. , 2007, American journal of epidemiology.

[9]  R. Hays,et al.  Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. , 2007, Arthritis and rheumatism.

[10]  T. Hyphantis,et al.  The impact of psychological functioning upon systemic sclerosis patients' quality of life. , 2007, Seminars in arthritis and rheumatism.

[11]  M. Suarez‐Almazor,et al.  Disease and symptom burden in systemic sclerosis: a patient perspective. , 2007, The Journal of rheumatology.

[12]  P. Merkel,et al.  Systemic sclerosis - continuing progress in developing clinical measures of response. , 2007, The Journal of rheumatology.

[13]  Richard W. Martin,et al.  Outcome measurements in scleroderma: results from a delphi exercise. , 2007, The Journal of rheumatology.

[14]  M. Revel,et al.  Assessing disability and quality of life in systemic sclerosis: construct validities of the Cochin Hand Function Scale, Health Assessment Questionnaire (HAQ), Systemic Sclerosis HAQ, and Medical Outcomes Study 36-Item Short Form Health Survey. , 2007, Arthritis and rheumatism.

[15]  M. Weisman,et al.  Medical signs and symptoms associated with disability, pain, and psychosocial adjustment in systemic sclerosis. , 2007, The Journal of rheumatology.

[16]  O. Chassany,et al.  Impact of pain in health related quality of life of patients with systemic sclerosis. , 2006, Rheumatology.

[17]  P. Carreira.  'Quality of pain' in systemic sclerosis. , 2006, Rheumatology.

[18]  G. Hruby,et al.  Mild, moderate, or severe pain categorized by patients with cancer with bone metastases. , 2006, Journal of palliative medicine.

[19]  C. Schentag,et al.  Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. , 2006, The Journal of rheumatology.

[20]  R. Cattaneo,et al.  systemic sclerosis : correlations with indexes of disease activity and severity , disability , and depressive symptoms , 2005 .

[21]  Walter Grassi,et al.  Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale , 2004, European journal of pain.

[22]  Davi M. D'Agostino,et al.  Health-related quality of life in systemic sclerosis as measured by the Short Form 36: relationship with clinical and biologic markers. , 2004, Arthritis and rheumatism.

[23]  A. Herrick,et al.  Systemic sclerosis: patients' perceptions of their condition. , 2003, Arthritis and rheumatism.

[24]  G. Valentini.  The assessment of the patient with systemic sclerosis. , 2003, Autoimmunity reviews.

[25]  M. Suarez‐Almazor,et al.  Current status of outcome measure development for clinical trials in systemic sclerosis. Report from OMERACT 6. , 2003, The Journal of rheumatology.

[26]  T. Sokka.  Assessment of pain in patients with rheumatic diseases. , 2003, Best practice & research. Clinical rheumatology.

[27]  J. Haythornthwaite,et al.  Psychologic factors in scleroderma. , 2003, Rheumatic diseases clinics of North America.

[28]  T. Medsger.  Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. , 2003, Rheumatic diseases clinics of North America.

[29]  Richard W. Martin,et al.  Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon. , 2002, Arthritis and rheumatism.

[30]  T. Kvien,et al.  Preferences for improved health examined in 1,024 patients with rheumatoid arthritis: pain has highest priority. , 2002, Arthritis and rheumatism.

[31]  D. M. van der Heijde,et al.  Use of a numerical rating scale as an answer modality in ankylosing spondylitis-specific questionnaires. , 2002, Arthritis and rheumatism.

[32]  Margaret T May,et al.  Regression Modelling Strategies with Applications to Linear Models, Logistic Regression, and Survival Analysis. Frank E Harrell Jr, New York: Springer 2001, pp. 568, $79.95. ISBN 0-387-95232-2. , 2002 .

[33]  J. Haythornthwaite,et al.  The impact of pain and symptoms of depression in scleroderma , 2002, Pain.

[34]  J. Farrar,et al.  Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale , 2001, PAIN.

[35]  L. Urbán,et al.  Mechanisms of inflammatory pain. , 2001, British journal of anaesthesia.

[36]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[37]  M. Mayes,et al.  Correlates of the disability index of the health assessment questionnaire: a measure of functional impairment in systemic sclerosis. , 1999, Arthritis and rheumatism.

[38]  A. Silman,et al.  A disease severity scale for systemic sclerosis: development and testing. , 1999, The Journal of rheumatology.

[39]  L. Wilson.  Cost-of-illness of scleroderma: the case for rare diseases. , 1997, Seminars in arthritis and rheumatism.

[40]  V. Malcarne,et al.  Psychological adjustment to systemic sclerosis. , 1996, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[41]  J. Poole,et al.  The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. , 1991, Arthritis care and research : the official journal of the Arthritis Health Professions Association.

[42]  P. Tugwell,et al.  Reliability of pain scales in the assessment of literate and illiterate patients with rheumatoid arthritis. , 1990, The Journal of rheumatology.

[43]  T. Pincus,et al.  A simplified twenty-eight-joint quantitative articular index in rheumatoid arthritis. , 1989, Arthritis and rheumatism.

[44]  T. Medsger,et al.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. , 1988, The Journal of rheumatology.

[45]  Leroy Ec,et al.  A modified scleroderma skin scoring method. , 1986 .

[46]  L. Hedges.  Estimation of effect size from a series of independent experiments. , 1982 .

[47]  A. Masi.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). , 1980, Bulletin on the rheumatic diseases.

[48]  James F. Fries,et al.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. , 1980, Arthritis and rheumatism.

[49]  J. Ioannidis,et al.  Mortality in systemic sclerosis: an international meta-analysis of individual patient data. , 2005, The American journal of medicine.

[50]  M. Mayes.  Scleroderma epidemiology. , 2003, Rheumatic diseases clinics of North America.

[51]  C. Loadholt,et al.  A modified scleroderma skin scoring method. , 1986, Clinical and experimental rheumatology.

[52]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .